» Articles » PMID: 35445430

A Comprehensive Review of Recent Advances in the Biological Activities of 1,2,4-oxadiazoles

Overview
Specialty Pharmacy
Date 2022 Apr 21
PMID 35445430
Authors
Affiliations
Soon will be listed here.
Abstract

Nitrogen heterocycles play an essential role in medication development. The 1,2,4-oxadiazole heterocycle has been extensively studied, yielding a large variety of molecules with varied biological functions. The 1,2,4-oxadiazole shows bioisosteric equivalency with ester and amide moieties. In recent years, the 1,2,4-oxadiazole nucleus has received a lot of attention in medicinal chemistry. It was thought to be a pharmacophore component in the production of biologically intriguing drugs. This review presents a comprehensive overview of the recent achievements in the biological activities of 1,2,4-oxadiazoles as potential antimicrobial, anticancer, anti-inflammatory, neuroprotective, and antidiabetic agents. The structure-activity relationship and mechanisms of action are also reviewed.

Citing Articles

Structural, CSD, Molecular Docking, Molecular Dynamics, and Hirshfeld Surface Analysis of a New Mesogen, Methyl-4-(5-(4-(octyloxy)phenyl)-1,2,4-oxadiazol-3-yl)benzoate.

Mohandas P, Abdul Salam A, Shenoy T, Maddasani S, Pal S, Yelamaggad C ACS Omega. 2025; 10(5):4336-4352.

PMID: 39959081 PMC: 11822514. DOI: 10.1021/acsomega.4c06520.


Preparation and kinetic studies of a new antibacterial sodium alginate gelatin hydrogel composite.

ElTatawy R, Ismail A, Ayoup M, Ismail M, Fetouh H Sci Rep. 2024; 14(1):29206.

PMID: 39587189 PMC: 11589701. DOI: 10.1038/s41598-024-80453-8.


Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors.

Mohamed A, Abou-Ghadir O, Mostafa Y, Dahlous K, Brase S, Youssif B Front Chem. 2024; 12:1447618.

PMID: 39281035 PMC: 11393688. DOI: 10.3389/fchem.2024.1447618.


Discovery of FO-4-15, a novel 1,2,4-oxadiazole derivative, ameliorates cognitive impairments in 3×Tg mice by activating the mGluR1/CaMKIIα pathway.

Luo Z, Guo J, Pang S, Dong W, Ma J, Zhang L Acta Pharmacol Sin. 2024; 46(1):66-80.

PMID: 39152295 PMC: 11696799. DOI: 10.1038/s41401-024-01362-0.


Novel Hydroxamic Acids Containing Aryl-Substituted 1,2,4- or 1,3,4-Oxadiazole Backbones and an Investigation of Their Antibiotic Potentiation Activity.

Zhukovets A, Chernyshov V, Almukhametov A, Seregina T, Revtovich S, Kasatkina M Int J Mol Sci. 2024; 25(1).

PMID: 38203266 PMC: 10779255. DOI: 10.3390/ijms25010096.